Skip to main content

CITIGROUP INC

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in IOVA

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$3,669,668
+$3,382,814 QoQ
Shares Held
882,132
+979.4% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Derivatives in IOVA

reported options exposure · as of Sep 30, 2023
CallValue
$0
CallShares
0
PutValue
$227,500
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. IOVA ranks #83 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,669,668 882,132
2026-03-31 $286,854 81,725
2025-12-31 $288,123 105,540
2025-09-30 $888,755 409,565
2025-06-30 $1,229,542 714,851
2025-03-31 $1,792,577 538,312
2024-12-31 $3,581,909 484,042
2024-09-30 $1,960,293 208,764
2024-06-30 $1,108,219 138,182
2024-03-31 $8,001,243 539,895
2023-12-31 $6,129,270 753,908
2023-09-30 $227,500 50,000
2023-09-30 $4,265,254 937,419
2023-06-30 $4,416,196 627,301
2023-06-30 $352,000 50,000
2023-06-30 $352,000 50,000
2023-03-31 $7,714,760 1,262,645
2023-03-31 $549,900 90,000
2023-03-31 $549,900 90,000
2022-12-31 $3,318,645 519,350
2022-09-30 $5,462,266 570,174
2022-06-30 $5,293,369 479,472
2022-06-30 $4,416,000 400,000
2022-03-31 $1,503,460 90,298
2021-12-31 $4,618,997 241,959
2021-09-30 $3,027,039 122,751
2021-06-30 $5,563,725 213,825
2021-03-31 $5,230,452 165,207
2020-12-31 $2,238,753 48,249
2020-09-30 $1,336,155 40,588
2020-06-30 $7,716,386 281,107
2020-03-31 $3,635,793 121,436